News - Generics


Current filters:


Popular Filters

1171 to 1195 of 1236 results

India tells UN meeting it will not accept data exclusivity as part of FTA with EU


India formally announced at the UN High Level Meeting on HIV and AIDS held in New York, USA, earlier…


EU generic drugmakers launch code of conduct on MAA slots


The European Generic medicines Association (EGA) says it has officially launched a code of conduct on…


Canada’s PMPRB reports slow-down in pharma sales


In its annual report for 2010 released to Canada’s Parliament last week, the Patented Medicine Prices…

GenericsMarkets & MarketingNorth AmericaPatentsPharmaceuticalPoliticsPricing

Rise in M&A for China's pharmaceutical sector forecast by KPMG


Both multinationals drugmakers and large domestic players are set to grab a larger share of the pharmaceutical…

Asia-PacificGenericsHealthcareMergers & AcquisitionsPharmaceutical

Joint ventures in generics to boost Indian pharma industry


The Indian pharmaceutical industry is moving towards the adoption and development of generic drugs, which…

Asia-PacificGenericsMarkets & MarketingMergers & Acquisitions

US Medicaid drug lists cost more, deliver less, claims news study


The USA’s Medicaid program is likely paying far more than necessary for medications and not offering…

GenericsHealthcareNorth AmericaPharmaceuticalPricing

K-V Pharma sells generics unit to Zydus for $60 million


USA-based K-V Pharmaceutical (NYSE: KVa/KVb) has entered into a definitive agreement to divest Nesher…

GenericsK-V PharmaceuticalMergers & AcquisitionsNesher PharmaZydus Cadila

Generic drugmakers call to make Europe the “medicines manufacturer of the world”


The key message delivered at the annual conference of the European Generic medicines Association (EGA)…

EuropeGenericsMarkets & MarketingRegulation

AstraZeneca plans R&D center in Russia and Novartis breaks ground on new facility


In yet more illustrations of multinational drug majors getting a foot hold in the fast-growing BRIC (Brazil,…


Health care investments in GCC nations spur pharma growth, says IHS


Demand for health care services in Gulf Cooperation Council (GCC) member states is on a strong upward…


Exports will be the key driver of growth for Czech pharma, says BMI


Disputes between pharmaceutical industry associations and the Czech government have created uncertainty…

EuropeGenericsMarkets & MarketingPharmaceuticalPolitics

China drug formulation market could reach $150 billion by 2015


It has been well recognized that the drug formulation has been one of the valued-added technologies for…

Asia-PacificGenericsMarkets & MarketingRegulation

US generics group GPhA voices worries on TPP agreement negotiations


The USA’s Generic Pharmaceutical Association (GPhA) says that it has sent a letter to President…

BiotechnologyGenericsMarkets & MarketingNorth AmericaPatents

Dr Reddy’s warned by US FDA over API facility in Mexico


Indian generic drug major Dr Reddy’s Laboratories (NYSE:RDY) revealed yesterday that its wholly-owned…

Dr Reddy's LaboratoriesGenericsNorth AmericaRegulationSouth America

CETA with EU would wipe out Canada’s drug savings, says generic drugmakers, but Rx& D sees benefits


The European Union is in negotiations for a comprehensive economic and trade agreement (CETA) with Canada.…

EuropeGenericsMarkets & MarketingNorth AmericaPatentsPharmaceuticalPolitics

Changing of the Guard begins in biotech sector


The biotechnology sector is bracing for change this year as a flurry of "biosimilar" or "biogeneric"…

BiotechnologyGenericsMarkets & MarketingNorth AmericaRegulation

EPHA calls for transparency of European medicines pricing


In the framework of the European Commission consultation of the possible revision of the directive on…


UK OFT evaluation of Napp case finds increased competition in morphine market


The UK’s Office of Fair Trading (OFT) has published an evaluation of its 2001 abuse of dominance…

EuropeGenericsMarkets & MarketingMorphineNapp PharmaceuticalsNeurologicalPricing

FDA denies Citizen Petition on generic Combivir 180-day exclusivity “First Applicant” issue


Last week, in a seven-page response, the US Food and Drug Administration denied an October 18, 2010 Citizen…

CombivirGenericsLegalLupinNorth AmericaPatentsTeva Pharmaceutical Industries

Mylan to rebrand Matrix Labs and launch Rx products in India


US generics major Mylan (Nasdaq: MYL) says that it plans to rebrand its Hyderabad, India-based subsidiary…

Asia-PacificGenericsMarkets & MarketingMatrixMylan Laboratories

1171 to 1195 of 1236 results

Back to top